VICKERS VANTAGE CORP I -CW27(NASDAQ:SCLXW) stock News

SCLXW Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase

7 days ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI

8 days ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

8 days ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in

9 days ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management

10 days ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

11 days ago - By: Scilex Holding Company - Mentions: SCLX

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

a month ago - By: Scilex Holding Company - Mentions: SCLX

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination

a month ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at

2 months ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

3 months ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a

4 months ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

5 months ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional

5 months ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional

5 months ago - By: Scilex Holding Company - Mentions: SCLX

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

6 months ago - By: Yahoo Finance - Mentions: RY RY.CA JPM UBS ...

TD Synnex price target lowered to $145 from $165 at RBC Capital

6 months ago - By: Yahoo Finance - Mentions: RY RY.CA SCLX APA ...

Scilex downgraded to Hold from Buy at D. Boral Capital

6 months ago - By: Yahoo Finance - Mentions: IVZ APA SCLX SNX ...

VICKERS VANTAGE CORP I -CW27 (SCLXW) Stock News

SCLXW Latest News, Press Relases and Analysis

Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase

Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI

Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in

Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination

Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a

Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal

Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional

Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional

Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

TD Synnex price target lowered to $145 from $165 at RBC Capital

Scilex downgraded to Hold from Buy at D. Boral Capital

Gold and Bonds' Safe Haven Allure May be Fading With Bitcoin Emergence